science of covid-19: "host-directed therapeutics discovery and correlates of disease severity"
Published 4 years ago • 327 plays • Length 1:37:31Download video MP4
Download video MP3
Similar videos
-
1:15:41
science of covid-19: “the neutralizing antibody response to sars-cov-2”
-
58:54
science of covid-19: "a discussion with dr. angela rasmussen"
-
1:07:24
"host factor targeted drug discovery for sars-cov-2 through an international collaboration”
-
1:15:04
science of covid-19: epidemiology of covid-19: what we know, what we need to know
-
1:06:33
dr. angela rasmussen: demystifying covid-19. sars-cov2 therapeutics and vaccines
-
58:05
science of covid-19: evolutionary potential of the sars-cov-2 receptor binding domain (rbd)
-
46:39
eli boritz: "emergence of sars-cov-2 variants under host immune pressure during acute covid-19"
-
56:52
science of covid-19: "neurological complications of coronaviruses"
-
11:51
inside the lab that invented the covid-19 vaccine
-
1:33:15
science of covid-19: "the molecular biology of coronavirus infection."
-
1:02:09
coronaviruses 101: focus on molecular virology
-
1:25:48
shane crotty: "adaptive immunity and immune memory to sars-cov-2 after covid-19"
-
1:14:27
science of covid-19: "deployment of convalescent plasma against covid-19"
-
1:21:10
dr. angela rasmussen: demystifying covid-19. the science of sars-cov2 epidemiology and transmission
-
44:12
michel nussenzweig: "fighting covid-19 with neutralizing antibodies"
-
1:02:34
science of covid-19: "going retro and translational in a time of covid"
-
1:04:18
science of covid-19: "the cliahub - student volunteer run covid testing"
-
1:25:07
dr. angela rasmussen: demystifying covid-19. the science of sars-cov-2 virology and immunology
-
55:21
ravindra gupta: "sars-cov-2 evolution during treatment of chronic infection"
-
1:12:04
michael mina: "covid-19 testing: where science, policy and regulation collide"
-
1:12:55
"immune history and sars-cov-2 antibody responses: lessons learned from influenza viruses”
-
1:12:58
science of covid-19: "de novo design of sars-cov2 candidate diagnostics, therapeutics and vaccines"